Pages

Showing posts with label Clinical pharmacy Pharmacist. Show all posts
Showing posts with label Clinical pharmacy Pharmacist. Show all posts

Friday, 24 July 2015

Treatment for myocardial infarction



1. Oxygen — Used to maintain blood oxygenation as well as tissue and
cardiac O2 levels.

2. Aspirin — If administered when myocardial infarction is detected,
the antiplatelet properties of aspirin may reduce the overall size of
the infarction.

3. Thrombolytic therapy — If employed in the first 1 to 4 hours following
the onset of a myocardial infarction, these drugs may dissolve
clots in coronary blood vessels and re-establish blood flow.

4. Vasodilator drugs — Intravenous nitroglycerin can increase blood
flow to the myocardium and reduce myocardial work.

5.β-Blockers — Blunt the effect of catecholamine release on the myocardium,
reduce heart rate and myocardial work.

6. Pain management — Sublingual nitroglycerin, morphine if necessary

7. Antiarrhythmia drugs — To treat and prevent a number of potentially
life-threatening arrhythmias that might arise following a myocardialinfarction.

8. ACE inhibitors — Drugs that block activation of the renin–angiotensin
system and thus reduce the negative effects of vasoconstriction
and salt and water retention on the myocardium.


Types of Drug Information Questions






ADVERSE DRUG REACTIONS
Adverse reactions
Allergies
Teratogenicity
Toxicology

DOSING
Age-specific dosing
Dosing in patients with altered organ function (liver,
kidneys)
Indication-specific dosing

DRUG ADMINISTRATION
Commercial dosage form alterations (crushing, dissolving)
Drug administration methods
Product preparation (reconstitution, admixing,
compounding)
Compatibility, stability, and storage
Timing (with or without food or enteral products)

DRUG INTERACTIONS
Drug-disease interactions
Drug-drug interactions
Drug-food interactions
Drug–laboratory test interactions
Drug-nutrient interactions

INDICATIONS AND THERAPEUTIC USE
Approved drugs
Investigational drugs
Unapproved drugs

POISONINGS
Signs and symptoms
Treatment

PRODUCT-SPECIFIC CONCERNS
Constituents (sugars, dyes, adjuvants, alcohol)
Formulations
Identification
Storage

MISCELLANEOUS
Drug use during pregnancy and lactation
Pharmacoeconomics
Product-specific assays
Veterinary drug information